The U.S. government on Thursday proposed a rule to end the industry-wide system of after-market discounts called rebates that pharmacy benefit managers (PBMs) receive from drugmakers, a practice that has been under increased scrutiny.
from Reuters: Health News https://reut.rs/2Ux8jnD
via IFTTT
from Reuters: Health News https://reut.rs/2Ux8jnD
via IFTTT
Post a Comment